| 摘要 |
The present invention relates to a method for assessing Alzheimer's disease in vitro comprising measuring the level of HSP27, or a variant thereof in a sample collected from an individual, wherein an altered level of said protein, or a variant thereof, is indicative that said individual suffers from Alzheimer's disease. Furthermore, the present invention relates to a method for monitoring the progression of the Alzheimer's disease in vitro comprising measuring the level of HSP27, or a variant thereof in a sample collected from an individual, wherein an altered level of HSP27 compared with an earlier measurement of the level of HSP27, or a variant thereof, is indicative for the progression of Alzheimer's disease of said individual.
|
